| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/HUPA.2001.25902 |
| P698 | PubMed publication ID | 11486167 |
| P50 | author | Kenneth J. Pienta | Q6390246 |
| Mark Rubin | Q37375521 | ||
| P2093 | author name string | Day ML | |
| Mucci NR | |||
| Fecko A | |||
| Figurski J | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 690-697 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Human Pathology | Q15756731 |
| P1476 | title | E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology | |
| P478 | volume | 32 |
| Q36798100 | 3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer |
| Q27302113 | A Novel Role of E-Cadherin-Based Adherens Junctions in Neoplastic Cell Dissemination |
| Q36611936 | A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. |
| Q48026733 | A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells |
| Q38945197 | ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1. |
| Q53352238 | Aberrant expression of E-cadherin and beta-catenin in human prostate cancer |
| Q38696010 | Activation of Vimentin is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells |
| Q42444695 | Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis |
| Q64085337 | Alterations of COX-2, HER-2/neu and E-Cadherin protein expression in the prostatic adenocarcinoma: preliminary findings |
| Q60367930 | Analysis of membrane-bound complement regulatory proteins in prostate cancer |
| Q36615956 | Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer. |
| Q33295288 | BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo |
| Q40057893 | Beta-catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1. |
| Q38637064 | Cadherin-mediated cell-cell interactions in normal and cancer cells |
| Q42472874 | Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. |
| Q93064621 | Centrosome loss results in an unstable genome and malignant prostate tumors |
| Q28539356 | Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer |
| Q40150065 | Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin |
| Q83823291 | CyclinD1, p53, E‐cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: A tissue array analysis |
| Q35060298 | Defining aggressive prostate cancer using a 12-gene model |
| Q34088774 | E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. |
| Q24802882 | E-cadherin expression in primary carcinomas of the breast and its distant metastases |
| Q38561949 | E-cadherin plasticity in prostate cancer stem cell invasion |
| Q37730957 | Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis |
| Q30724105 | Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases |
| Q64243517 | Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells |
| Q36857803 | Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases |
| Q41552614 | Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer |
| Q33351622 | Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? |
| Q41761066 | Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer. |
| Q35672517 | Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells |
| Q40157152 | Expression of the cytoskeleton linker protein ezrin in human cancers |
| Q38703189 | FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na+-K+-ATPase subunit in the 4T1 mouse breast cancer model |
| Q28300097 | FYN is overexpressed in human prostate cancer |
| Q38780754 | Formation of intracellular lumina in human prostate carcinoma (DU145) cells, maturation into signet cells, and the cribriform morphology of tumors |
| Q35772604 | Genes differentially expressed in prostate cancer |
| Q36358322 | Genomics of prostate cancer: is there anything to "translate"? |
| Q42142969 | Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells |
| Q47107385 | Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner |
| Q34360616 | Human prostate cancer risk factors |
| Q31044596 | Identification of key genes associated with gastric cancer based on DNA microarray data |
| Q35755276 | Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease |
| Q35006897 | Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer |
| Q25257221 | Internet-based Profiler system as integrative framework to support translational research |
| Q30677893 | Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study |
| Q39615993 | Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion |
| Q86505500 | Lipocalin-2 is associated with a good prognosis and reversing epithelial-to-mesenchymal transition in pancreatic cancer |
| Q38991030 | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis |
| Q36424265 | Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression |
| Q37917310 | Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation |
| Q38034126 | Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents |
| Q35070139 | Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. |
| Q24672410 | Molecular pathology of prostate cancer |
| Q44432097 | Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer |
| Q39441186 | Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent |
| Q58050657 | New Development of Oncogenetics—High Throughput Tissue Microarray Technology |
| Q36829582 | New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration |
| Q36023904 | PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer |
| Q47104255 | PRL‑3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients |
| Q73264118 | Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model |
| Q39128975 | Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer |
| Q36165373 | PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells |
| Q28278555 | Prostate cancer and the met hepatocyte growth factor receptor |
| Q24673038 | Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements |
| Q36831102 | Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis |
| Q30660370 | Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model |
| Q28237131 | SIGLEC12, a Human-specific Segregating (Pseudo)gene, Encodes a Signaling Molecule Expressed in Prostate Carcinomas |
| Q39021336 | SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin |
| Q39670420 | Suppression of Migration and Invasion of PC3 Prostate Cancer Cell Line via Activating E-Cadherin Expression by Small Activating RNA |
| Q37601733 | T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance |
| Q92410904 | The Tumor Microenvironments of Lethal Prostate Cancer |
| Q34513833 | The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells |
| Q33670411 | The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control |
| Q30828400 | Tissue microarrays |
| Q38088419 | Tissue microarrays and quantitative tissue-based image analysis as a tool for oncology biomarker and diagnostic development |
| Q35183639 | Tissue microarrays in cancer diagnosis |
| Q35600009 | Tissue microarrays in drug discovery |
| Q42509234 | Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells |
| Q37957896 | Using molecular markers to help predict who will fail after radical prostatectomy |
| Q42141470 | Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for cl |
| Q37862995 | Wnt signaling in prostate development and carcinogenesis |
| Q39268465 | Xenotransplanted Human Prostate Carcinoma (DU145) Cells Develop into Carcinomas and Cribriform Carcinomas: Ultrastructural Aspects |
Search more.